SlateStone Wealth’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,734
Closed -$239K 296
2025
Q2
$239K Buy
+2,734
New +$214K 0.02% 264
2025
Q1
Sell
-2,630
Closed -$205K 290
2024
Q4
$205K Buy
+2,630
New +$195K 0.02% 271
2024
Q3
Sell
-2,294
Closed -$260K 296
2024
Q2
$260K Buy
2,294
+521
+29% +$65.9K 0.03% 254
2024
Q1
$246K Buy
+1,773
New +$223K 0.02% 250

Other funds holding DXCM

SlateStone Wealth's DXCM Position: Q3 2025 in Review

SlateStone Wealth sold out of DexCom (DXCM) in Q3 2025, closing a stake of 2,734 shares — an estimated $239K sold.

SlateStone Wealth first reported a position in DXCM in Q1 2024 and held it in 4 quarters. The position peaked at $260K in Q2 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • SlateStone Wealth reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • SlateStone Wealth sold 2,734 DexCom shares in Q3 2025, an estimated $239K.
  • SlateStone Wealth first reported a position in DexCom in Q1 2024 and held it in 4 quarters.
  • SlateStone Wealth's DexCom position peaked at $260K in Q2 2024.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on SlateStone Wealth's 13F filing for Q3 2025, filed 5 Nov 2025.